One-Year Outcomes After Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention: The T-TIME Randomized Trial.
Maznyczka AM, McCartney PJ, Eteiba H, Greenwood JP, Muir DF, Chowdhary S, Gershlick AH, Appleby C, Cotton JM, Wragg A, Curzen N, Oldroyd KG, Lindsay M, McEntegart M, Rocchiccioli JP, Shaukat A, Good R, Watkins S, Robertson K, Malkin C, Martin L, Gillespie L, Weir RA, Ford TJ, Petrie MC, Murphy A, Petrie CJ, Ramparsad N, Wetherall K, Fox KA, Ford I, McConnachie A, Berry C; T-TIME Group.
Maznyczka AM, et al.
Circ Cardiovasc Interv. 2020 Feb;13(2):e008855. doi: 10.1161/CIRCINTERVENTIONS.119.008855. Epub 2020 Feb 11.
Circ Cardiovasc Interv. 2020.
PMID: 32069113
Free article.
Clinical Trial.
No abstract available.